Clinical Trials Logo

Interstitial Lung Disease clinical trials

View clinical trials related to Interstitial Lung Disease.

Filter by:

NCT ID: NCT04299945 Active, not recruiting - Clinical trials for Interstitial Lung Disease

Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease

Start date: January 29, 2020
Phase: N/A
Study type: Interventional

Exercise training as part of a structured pulmonary rehabilitation program is a key factor in improving quality of life and symptoms in people with interstitial lung disease (ILD). Optimal methods of exercise training are yet to be explored in ILD. Drinking beetroot juice, which is rich in nitrate, has been shown to improve exercise performance in a variety of groups, but its effects in ILD have not been tested. The purpose of this study is to determine if drinking nitrate-rich beetroot juice can improve exercise performance compared to drinking nitrate-free beetroot juice in people with ILD.

NCT ID: NCT04273867 Completed - Clinical trials for Interstitial Lung Disease

Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis

CHP-HRQOL
Start date: July 10, 2020
Phase:
Study type: Observational

The objective of this study is to administer and validate a disease specific health related quality of life (HRQOL) survey for patients with Chronic Hypersensitivity Pneumonitis (CHP).

NCT ID: NCT04227535 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2

TRANSLATE2
Start date: February 3, 2020
Phase:
Study type: Observational

The overall goal of this study is to identify risk and prognosis factors of Interstitial Lung Disease (ILD) in patients with rheumatoid arthritis (RA).

NCT ID: NCT04193592 Not yet recruiting - Clinical trials for Interstitial Lung Disease

Efficacy and Safety of Pirfenidone Treatment in HPS-ILD

PEARL
Start date: December 1, 2019
Phase: Phase 2
Study type: Interventional

This research study will explore the safety and efficacy of the drug, pirfenidone, in patients with a diagnosis of Hermansky-Pudlak Syndrome (HPS) who have an associated interstitial lung disease (ILD) over a planned period of 56 weeks.

NCT ID: NCT04184180 Completed - COPD Clinical Trials

Effects of Inpatient Pulmonary Rehabilitation on Frailty in Patients After Lung-Transplantation

Start date: December 2, 2019
Phase:
Study type: Observational

Frailty is closely linked to the success of lung transplantations (LTx) (1,2). Studies have shown that frailty causes a diminished physical performance in candidates for LTx and an increased 30 day rate of re-hospitalization after surgery. Furthermore, frailty is associated with a higher one-year-mortality rate after LTx in frail compared to non-frail patients (1,3,4). Some evidence that frailty in LTx-candidates can be decreased by a suitable rehabilitation program suggests that improving the frailty status in post-LTx patients can be a further strategy to contribute to an overall success in LTx. However, at the moment these possible benefits are not investigated yet. Therefore the aim of this study is to observe the effect of a three-week inpatient rehabilitation on frailty in patients after LTx.

NCT ID: NCT04159584 Completed - Clinical trials for Interstitial Lung Disease

Pilot Study: The Effects of Medical Music on Anxiety in Patients With ILD

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

This is uncontrolled, interventional feasibility study for determining the effects medical music on anxiety levels in subjects with ILD. Enrolled subjects will be asked to complete questionnaires and undergo physiologic measurements prior to listening to medical music. The music intervention will be for approximately 30 minutes. Post intervention questionnaires and physiologic measurements will be done.

NCT ID: NCT04139356 Recruiting - COPD Clinical Trials

The Effect of Spontaneous Respiration on Pulse-oximetry Measurements

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This is a study designed to measure, characterize and describe changes on pulse-oxymetry values produced as a result of deep breaths in patients with stable chronic hypoxemic respiratory failure.

NCT ID: NCT04138173 Completed - Clinical trials for Interstitial Lung Disease

Enhancing Physical Activity in Patients With Interstitial Lung Disease

Start date: January 14, 2020
Phase: N/A
Study type: Interventional

The level of physical activity (PA) has been shown to be an important predictor for morbidity and mortality in patients with chronic respiratory diseases such as COPD and more recently Idiopathic Pulmonary Fibrosis. Physical inactivity is a common feature of patients with chronic respiratory diseases. Whereas pulmonary rehabilitation is known to result in benefits in exercise capacity, symptoms and quality of life, these gains will not automatically translate into increases in physical activity. Therefore, the present study aims to investigate the effect of a physical activity coaching program on the physical activity level of patients with interstitial lung disease.

NCT ID: NCT04136223 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression

BERTHA
Start date: March 1, 2021
Phase:
Study type: Observational

BERTHA study´s primary objective is to characterize Rheumatoid Arthritis-associated Interstitial Lung Disease (RA-ILD) progression and to define a combination of biomarkers, genetic and clinical variables capable of identifying patients at risk of RA-ILD progression

NCT ID: NCT04098094 Recruiting - Clinical trials for Interstitial Lung Disease

Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases

DVD
Start date: September 19, 2019
Phase:
Study type: Observational

Observational study in patients with chronic respiratory diseases (chronic obstructive pulmonary diseases, bronchiectasis, interstitial lung diseases, neuromuscular diseases, obesity-hypoventilation syndrome...) admitted in intensive care unit for acute respiratory failure. The main objective is to determine the prevalence of right ventricular (RV) dysfunction in this population and to analyze the impact of such a complication on outcomes (survival at day-28, duration of non-invasive or mechanical ventilation, duration of hospital stay). RV function will be assessed by echocardiography at admission, after 3 days and at discharge. Plasma NT-proBNP and troponin levels will be collected.